Clik here to view.
武田薬品が一部の一般用医薬品およびノンコア資産のアシノへの売却を完了
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:4502/NYSE:TAK）（「武田薬品」）は本日、当社グロース＆エマージング マーケッツ ビジネス ユニット（GEM...
View ArticleClik here to view.
Only 82% of ASEAN Potential Human Development Index (HDI) Is Realized Due to...
TOKYO The ASEAN-Japan Centre (AJC), an intergovernmental organization of ASEAN and Japan based in Tokyo, just issued a paper on Trade in Health Related and Social Services. The paper provides an...
View ArticleClik here to view.
武田完成向Acino出售部分非处方药和非核心资产的交易
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（“武田”）今天宣布已完成其先前宣布的一项交易，即以逾2亿美元的总价值向Acino出售其增长与新兴市场业务部门(GEM...
View ArticleClik here to view.
武田同意以8.25亿美元向Hypera Pharma出让拉丁美洲部分非处方和非核心资产
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（“武田”）今天宣布，其已达成一项协议，将以8.25亿美元总价值将其位于拉丁美洲的专有部分非核心产品组合出让给在品牌处方、消费者健康和品牌仿制药领域处于领先地位的巴西最大制药公司Hypera S.A. (“Hypera...
View ArticleClik here to view.
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Rare Pediatric...
SAN DIEGO & MELBOURNE, Australia ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) and Neuren Pharmaceuticals Limited (ASX: NEU) announced today that the U.S. Food and Drug Administration (FDA) granted...
View ArticleClik here to view.
Clik here to view.
武田薬品： 新型コロナウイルス感染症（COVID-19）治療薬としての血漿分画製剤開発の開始について
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社は、米国時間3月4日、米国議会において、当社が新型コロナウイルスに感染されたハイリスク患者さんに対する治療薬として抗...
View ArticleClik here to view.
Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today will share with members of the United States Congress that it is initiating the...
View ArticleClik here to view.
モダン・ガバナンス9.0：新たなプレッシャーに直面して取締役の65%が外部情報源に指針を求めていることが、ディリジェント・インスティテュートの報告書で明らかに
ニューヨーク （ビジネスワイヤ） —...
View ArticleClik here to view.
Scientists from Merck and the Walter and Eliza Hall Institute of Medical...
KENILWORTH, N.J. & MELBOURNE, Australia Merck (NYSE: MRK), known as MSD outside the United States and Canada, and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia,...
View ArticleClik here to view.
现代治理9.0：Diligent研究院报告显示，面对新的压力，65%的董事寻求外部情报来源指导公司治理
纽约 (美国商业资讯)–据Diligent研究院(Diligent Institute)一份新报告显示，在审查日益严格的时代，公司董事在除了公司内部提供的报告之外，纷纷独自挖掘外部的信息来源。Diligent研究院是Diligent下属研究机构，后者是现代治理领域的领头羊，也是备受信赖的董事会洞察分析提供者，为全球超过1.7万家组织和65万领导者提供相关服务。...
View ArticleClik here to view.
Hot Topics Recap: Coronavirus
NEW YORK Following are the latest Coronavirus news releases and story ideas for reporters, bloggers and media outlets. These recaps, curated by Business Wire, provide reporters and bloggers around...
View ArticleClik here to view.
Why Functional Medicine is the Future of Healthcare
BANGKOK With the novel coronavirus (2019-nCoV) epidemic bringing parts of the world to a panic-stricken standstill, now is the best time to think about the state of one’s overall health and...
View ArticleClik here to view.
武田启动开发用于COVID-19的血浆衍生治疗药物
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(TOKYO:4502/NYSE:TAK)（“武田”）今天将与美国国会议员分享，它正在启动开发用于治疗COVID-19高危个体的抗SARS-CoV-2多克隆超免疫球蛋白(H-IG)，同时研究武田目前的市售和管线产品能否有效治疗感染患者。SARS-CoV-2是导致COVID-19的病毒。...
View ArticleClik here to view.
Wipro Recognized as a Leader in Everest Group PEAK Matrix™ Healthcare Payer...
EAST BRUNSWICK, N.J. & BANGALORE, India Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today...
View ArticleClik here to view.
バンテージ 2019レビュー：2019年は第4四半期の堅調な市場動向とM&Aを反映して製薬業界にとって傑出した1年に
ロンドン & ボストン & 東京 （ビジネスワイヤ） —...
View ArticleClik here to view.
Hot Topics Recap: Coronavirus
NEW YORK Following are the latest Coronavirus news releases and story ideas for reporters, bloggers and media outlets. These recaps, curated by Business Wire, provide reporters and bloggers around...
View ArticleClik here to view.
Hepalink Announces the Appointment of Healthcare Senior Executive Mr. Frank...
SHENZHEN, China Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SZSE: 002399), a China-based global pharmaceutical company targeting high-mortality diseases with significant unmet medical needs,...
View ArticleClik here to view.
TFF Pharmaceuticals Announces Engagement of Torreya Partners, LLC as...
AUSTIN, Texas TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film...
View ArticleClik here to view.
Cypress Announces Completion of CFIUS Review
SAN JOSE, Calif. Cypress Semiconductor Corp. (NASDAQ: CY) announced that Cypress has been informed today by the Committee on Foreign Investment in the United States (CFIUS) that CFIUS has completed...
View Article